Bonus Biogroup Ltd. is a biotechnology company, which engages in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
BBIXF stock price ended at $0.15 on Mercredi, after rising 50.00%
On the latest trading day Feb 11, 2026, the stock price of BBIXF rose by 50.00%, climbing from $0.15 to $0.15. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.15 and a high of $0.15. Alongside this price increase, trading volume also rose by 17.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 500 shares were traded, amounting to a market value of approximately $175.1M.
Signaux Techniques de BBIXF
Résumé des Signaux Techniques
Acheter des signaux 4
Signaux neutres 1
Signaux de vente 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
BBIXF présente actuellement 4 signaux d'achat et 2 signaux de vente. L'action est en tendance haussière depuis 12:00 AM, avec une variation totale du prix de 66.67% pendant cette période. En général, les indicateurs techniques indiquent une tendance Buy à moyen terme.
Signaux haussiers/baissiers pour BBIXF
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour BBIXF, vous aidant à prendre des décisions d'investissement éclairées.